DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS ⚠️ Small Study / Early Comparative Evidence
JAMA Network Open published interviews conducted 2021-2023 with 169 adults (mean age 70.8) considering edible cannabis for chronic pain, sleep, anxiety, or depression. Participants gravitated toward combination products despite uncertainty about dosing, onset, and interactions.
Clinical Considerations
- Combination THC-CBD products were chosen far more often than CBD-only or THC-only options, driven by perceived balanced symptom relief.
- Many participants framed cannabis as a last-resort alternative after physical therapy, sleep medications, and antidepressants failed.
- Concerns clustered around psychoactive effects, cognitive impairment, dependency, dosing uncertainty, and credibility of manufacturer claims.
- Sample was highly educated, predominantly White, Colorado-based, limiting generalizability across populations and product formulations.
Practice Applications
- Recognize that older patients may already be using edibles without disclosing it during medication reconciliation.
- Ask directly about cannabis use, ratios, and frequency when reviewing sleep, pain, and mood complaints.
- Interpret patient interest as a signal of unmet symptom burden, not necessarily a pharmacologic preference.
- Monitor for drug interactions, fall risk, and cognitive effects in older adults using THC-containing products.
